In the present study, we investigated the metabolic changes that occur in oxaliplatin-resistant CRC cells and identified increased purine metabolism, which mainly arises from the upregulation of IMPDH2 expression through the Wnt/β‐catenin pathway. This evidence concerns the gene IMPDH2 and colorectal carcinoma.